An Observational, Ambispective Cohort Study Evaluating the Long-term Effectiveness and Safety of Dinutuximab Beta or Conventional Treatment as Maintenance Therapy in Patients With High Risk Neuroblastoma First published 03/05/2022 Last updated 05/11/2026 EU PAS number:EUPAS46562 Study Ongoing